AK Adjutant 17+
Выбор антикоагулянта.
Vladimir Shapovalov
Designed for iPad
-
- Free
Screenshots
Description
For doctors:
- When choosing an anticoagulant for AF, it speeds up the decision-making process at times. This speed is achieved by using complex variables and all related parameters of all scales and formulas (Cockcroft-Gault, CKD-EPI, HAS-BLED, CHA2DS-VASC with the latest corrections) are entered once, not several times for each calculation! Parallel accounting for the presence / absence of ACS. Accounting for the presence/absence of stents in the coronary bed. That allows you to get the best recommendation. The calculation takes place on the fly, each new parameter instantly corrects the result (you can observe the intermediate one), but the most important thing is that you do not stay with the calculation results, but immediately receive a recommendation in text form, verified with the latest recommendations. You don't even need internet for this.
- When choosing an anticoagulant for PE/DVT, using the techniques described above, the program simultaneously calculates all the necessary scales and formulas (Geneva, Wells, PESI, Cockcroft-Gault, CKD-EPI, thrombosis recurrence predictive scale, VTE-BLEED, etc.).
- Algorithm for the use of rivaroxaban 2.5 mg.
- Collective scale of modification of the risk of bleeding (significant and non-significant). The scale is a composite of HAS-BLED, HEMORR2HAGES, ABC. You won't see this anywhere else.
- Collection of articles on AF and anticoagulant therapy (Internet connection required)
- Links to various educational events that deal in one way or another with the topic of anticoagulant therapy or the treatment of AF (internet connection required).
For teachers, lecturers, students:
- Allows you to easily and quickly simulate patients of varying complexity
- Using the application, you can quickly create clinical tasks (thematic)
- Can be helpful in mastering the recommendations
For patients:
- Simplified calculators for self-control.
- Self-learning information on atrial fibrillation, with different feed levels.
Disclaimer.
- the author does not bear any responsibility for the consequences that followed the use of the recommendations that the program generates.
- recommendations are advisory in nature and are not a guide to action.
- if you are not a certified medical specialist, then always remember that you should never use the recommendations generated by the program without consulting your doctor!
- if you are a specialist in the field of medicine, then all the responsibility for making a decision in a specific clinical situation lies with you (as always). Program recommendations are only supportive. Only you decide whether to use the information received or not.
Links:
- RSC recommendations from 2020 AF (https://scardio.ru/content/Guidelines/2020/Clinic_rekom_FP_TP.pdf)
CAD (https://scardio.ru/content/Guidelines/2020/Clinic_rekom_IBS.pdf)
- EHRA recommendations from 2021
AF (https://academic.oup.com/europace/article/23/10/1612/6247378#237648358)
- ESC recommendations from 2020:
AF (https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Atrial-Fibrillation-Management)
ACS (https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Acute-Coronary-Syndromes-ACS-in-patients-presenting-without-persistent-ST-segm)
- ESC with ERS Guidelines 2019:
PE(https://academic.oup.com/eurheartj/article/41/4/543/5556136)
- ESC consensus document 2017:
DVT(https://academic.oup.com/eurheartj/article/39/47/4208/3002647)
- CKD-EPI (https://pubmed.ncbi.nlm.nih.gov/19414839/)
- SCF Cockcroft-Gault (https://pubmed.ncbi.nlm.nih.gov/1244564/)
- Geneva (revised) (https://pubmed.ncbi.nlm.nih.gov/16461960/)
- HEMORR2HAGES (https://pubmed.ncbi.nlm.nih.gov/16504638/)
- ABC (https://academic.oup.com/eurheartj/article/37/20/1582/2570476)
- Wells rule (https://pubmed.ncbi.nlm.nih.gov/11453709/)
- PESI (https://pubmed.ncbi.nlm.nih.gov/16020800/)
What’s New
Version 7.12
Changes:
- Adjutant now relies on CHA2DS2-VA, in accordance with the latest ESC recommendations from 2024.
- Adjutant complies with the latest recommendations (as always)
- in all calculators, the side menu opening button has been moved (it is now a system button and is located at the top right)
- the appearance and layout of the TELA calculator for iPad and MAC has been improved.
- Annotations display has been improved
- in the main Adjutant calculator, it now divides recommendations into those that can be considered and those that should be considered.
- some graphic elements have been improved
- data handling has been optimized, due to which the application has become even faster and consumes less memory.
- now, if Adjutant has not updated automatically, then when you enter the application, a reminder will appear on the main screen, clicking on which will redirect you to the Adjutant page in the App Store.
Fixes:
- fixed the size of the month background in the calendar
PE calculator:
- fixed the situation when, when selecting therapy for secondary prevention after the first episode of PE/DVT, under certain conditions, upon reaching the criteria of “intermediate risk” of thrombosis recurrence, “low” risk could be displayed, which could be misleading (although the recommendation on tactics and drugs itself was correct).
- fixed the problem related to the fact that in the acute phase, when selecting therapy, if the patient has active cancer, a partial recommendation for the use of apixaban could be displayed, which could be misleading.
- fixed the error that led to the fact that the switch with active cancer could not be shown in the active phase if you have not yet selected the switches calculating the probability of PE.
- fixed the problem with the English localization of the graph annotations in the bleeding risk calculator.
App Privacy
The developer, Vladimir Shapovalov, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.
Data Not Collected
The developer does not collect any data from this app.
Privacy practices may vary based on, for example, the features you use or your age. Learn More
Information
- Provider
- Vladimir Shapovalov
- Size
- 9 MB
- Category
- Medical
- Compatibility
-
- iPhone
- Requires iOS 16.0 or later.
- iPad
- Requires iPadOS 16.0 or later.
- Mac
- Requires macOS 13.0 or later and a Mac with Apple M1 chip or later.
- Apple Vision
- Requires visionOS 1.0 or later.
- Languages
-
English, Russian
- Age Rating
- 17+ Frequent/Intense Medical/Treatment Information Infrequent/Mild Alcohol, Tobacco, or Drug Use or References
- Copyright
- © 2024 Шаповалов Владимир Анатольевич
- Price
- Free